Concentration and relative distribution of low-density lipoprotein subfractions in patients with metabolic syndrome defined according to the National Cholesterol Education Program criteria

被引:75
作者
Gazi, Irene
Tsimihodimos, Vasilis
Filippatos, Theodosios
Bairaktari, Eleni
Tselepis, Alexandros D.
Elisaf, Moses [1 ]
机构
[1] Univ Ioannina, Sch Med, Dept Internal Med, GR-45110 Ioannina, Greece
[2] Univ Ioannina, Sch Med, Clin Chem Lab, GR-45110 Ioannina, Greece
[3] Univ Ioannina, Dept Chem, Biochem Lab, GR-45110 Ioannina, Greece
来源
METABOLISM-CLINICAL AND EXPERIMENTAL | 2006年 / 55卷 / 07期
关键词
D O I
10.1016/j.metabol.2006.02.015
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
It has been proposed that the most common lipid abnormalities associated with the metabolic syndrome are elevated triglyceride and low high-density lipoprotein concentrations as well as the existence of small, dense low-density lipoprotein (LDL) particles. However, so far there are only limited clinical data concerning the distribution of LDL particles in patients with this syndrome. The aim of our study was to directly determine the concentration and relative distribution of LDL subfractions in patients with metabolic syndrome. One hundred seventy-five individuals were included. Patients with metabolic syndrome (n = 105) exhibited higher concentrations of dense LDL particles and lower mean LDL particle size than the control population (n = 70). Both of these parameters were significantly correlated with the number of components of metabolic syndrome. Multivariate analysis revealed that serum triglyceride concentration was the most important determinant of the presence of small, dense LDL particles. In conclusion, patients with metabolic syndrome exhibit higher concentrations of small, dense LDL subtractions than individuals who do not fulfill the criteria for the diagnosis of this syndrome. This increase is directly related to the number of components of metabolic syndrome and is mainly determined by the serum concentrations of triglycerides. (c) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:885 / 891
页数:7
相关论文
共 33 条
[1]
Interaction of very-low-density, intermediate-density, and low-density lipoproteins with human arterial wall proteoglycans [J].
Anber, V ;
Millar, JS ;
McConnell, M ;
Shepherd, J ;
Packard, CJ .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1997, 17 (11) :2507-2514
[2]
ATHEROGENIC LIPOPROTEIN PHENOTYPE - A PROPOSED GENETIC-MARKER FOR CORONARY HEART-DISEASE RISK [J].
AUSTIN, MA ;
KING, MC ;
VRANIZAN, KM ;
KRAUSS, RM .
CIRCULATION, 1990, 82 (02) :495-506
[3]
Association of apolipoprotein A5 variants with LDL particle size and triglyceride in Japanese Americans [J].
Austin, MA ;
Talmud, PJ ;
Farin, FM ;
Nickerson, DA ;
Edwards, KL ;
Leonetti, D ;
McNeely, MJ ;
Viernes, HM ;
Humphries, SE ;
Fujimoto, WY .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2004, 1688 (01) :1-9
[4]
AUSTIN MA, 1994, CLIN GENET, V46, P64
[5]
Metabolic origins and clinical significance of LDL heterogeneity [J].
Berneis, KK ;
Krauss, RM .
JOURNAL OF LIPID RESEARCH, 2002, 43 (09) :1363-1379
[6]
Low-density lipoprotein particle concentration and size as determined by nuclear magnetic resonance spectroscopy as predictors of cardiovascular disease in women [J].
Blake, GJ ;
Otvos, JD ;
Rifai, N ;
Ridker, PM .
CIRCULATION, 2002, 106 (15) :1930-1937
[7]
Relationship to insulin resistance of the Adult Treatment Panel III diagnostic criteria for identification of the metabolic syndrome [J].
Cheal, KL ;
Abbasi, F ;
Lamendola, C ;
McLaughlin, T ;
Reaven, GM ;
Ford, ES .
DIABETES, 2004, 53 (05) :1195-1200
[8]
The metabolic syndrome [J].
Eckel, RH ;
Grundy, SM ;
Zimmet, PZ .
LANCET, 2005, 365 (9468) :1415-1428
[9]
Einhorn Daniel, 2003, Endocr Pract, V9, P237
[10]
LDL particle size in relation to insulin, proinsulin, and insulin sensitivity -: The insulin resistance atherosclerosis study [J].
Festa, A ;
D'Agostino, R ;
Mykkänen, L ;
Tracy, RP ;
Hales, CN ;
Howard, BV ;
Haffner, SM .
DIABETES CARE, 1999, 22 (10) :1688-1693